2-Hydroxyisonicotinic Acid CAS 22282-72-0 Puritas >98.0% (GC) Factory Featured Image

2-Hydroxyisonicotinic Acid CAS 22282-72-0 Purity > 98.0% (GC) Factory

Description:

Nomen chemicum: 2-Hydroxyisonicotinicum Acid

Synonyma: 2-Hydroxypyridum-4-Acidi carboxylicum

CAS: 22282-72-0

Puritas: >98.0% (GC)

Aspectus: Alba ad lux Yellow vel Crystal

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 2-Hydroxyisonicotinic Acid (CAS: 22282-72-0) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	2-Hydroxyisonicotinic Acid
Synonyma	2-Acid.2-Hydroxypyridine-4-Acid carboxylicum;2-Oxo-1,2-Dihydropyridine-4-Acid carboxylicum;1,2-Dihydro-2-Oxopyridine-4-Carboxylic Acid
CAS Number	22282-72-0
CATTUS Number	RF-PI1864
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C6H5NO3
M. Pondus	139.11
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad lux Yellow vel Crystal
Puritas / Analysis Methodus	>98.0% (GC)
Puritas / Analysis Methodus	98.0~ 102.0% (Titration Neutralization)
Liquescens punctum	>300℃
Aqua Content (KF)	<0.50%
Audi Metals	<10ppm
Totalis immunditias	<2.00%
Infrared Imaginis	Conformat ut Structure
Proton NMR Spectrum	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

2-Acidum hydroxyisonicotinicum (CAS: 22282-72-0) uti potest intermedia organica vel intermedia pharmaceutica.2-Acidum hydroxyisonicotinicum adhibetur in synthesi selectivarum inhibitorum neuropeptidi Y Y5 attracti cibi inhibitores.Etiam usus est in optimization of p-subsitis residua HIV protease inhibitores.